- Price
- $30.86
- Day
- -1.78%
- Mkt Cap
- $1.78B
- 52W Range
- $19.14 – $34.28
- Volume
- 1.17M
- Beta
- 1.45
Find a company by name or ticker and open its page
Snapshot of fundamentals, performance, and 5D scores.
Business fundamentals and company information
Recent price action and historical returns
How the business makes money, by product and geography
Five lenses on the stock. Click any card to dive deeper.
How to read these dimensions
The five dimensions are independent lenses on a company, not a single combined score. Read them together rather than in isolation: where one dimension scores differently from the others is often the most useful place to focus your own research. Each score is built from rules and weights you can adjust, so treat them as a transparent starting point for your analysis, not a recommendation to buy or sell.
Recent news headlines and analyst price-target moves
Enovis Corporation $ENOV Shares Bought by Allspring Global Investments Holdings LLC
Allspring Global Investments Holdings LLC grew its holdings in shares of Enovis Corporation (NYSE: ENOV) by 38.0% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,045,360 shares of the company's stock after purchasing an additional 287,687 shares during
Enovis to Host Second Quarter 2026 Results Conference Call on August 6th
Dallas, TX, July 17, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its second quarter 2026 financial results on Thursday, August 6th, 2026 at 8:30 a.m. Eastern Time and issue an earnings press release earlier that morning. The live webcast and a presentation related to the call will be accessible from the "Investors" section of Enovis' website at www.enovis.com.